Patients with type 1 diabetes saw blood sugars improve with liraglutide

July 2, 2018 by Ellen Goldbaum, University at Buffalo

Researchers from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have found that adding liraglutide to insulin treatment for patients with type 1 diabetes results not only in better blood sugar control but simultaneous improvements in blood pressure, body weight and the amount of insulin patients need to take.

They reported their findings last Sunday at the annual meeting of the American Diabetes Association in Orlando, Florida.

"In 2011, we reported a small study with 14 participants showing that adding liraglutide to the insulin regimen of well-controlled type 1 resulted in many benefits," said Paresh Dandona, MD, Ph.D., SUNY Distinguished Professor and chief of the Division of Endocrinology, Diabetes and Metabolism in the Jacobs School and senior author on the study. Dandona sees patients at UBMD Internal Medicine.

"Now we have completed a larger study that again demonstrates that adding liraglutide to the insulin regimen significantly benefits the type 1 diabetic patient."

The 52-week, randomized double-blinded, placebo-controlled clinical trial involved 26 men and women who received a daily injection of liraglutide and 20 who received placebo for 26 weeks; after that, the trial was unblinded and those who had had the placebo were switched to the drug, while those on liraglutide continued to receive it. Ages ranged from 30 to 75 years.

Patients taking liraglutide saw 0.57 percent (from 7.9 to 7.45) reduction in their hemoglobin A1c, a measure of sugar in the blood, compared to placebo. Patients taking the drug also needed a significantly lower dose of insulin. There was also a reduction in systolic and weight loss averaging about 8 pounds over the duration of the study with liraglutide.

Dandona pointed out there was no significant increase in hypoglycemic episodes. Thus, liraglutide induced an improvement in diabetic control, along with a reduction in blood pressure and without causing hypoglycemia.

Explore further: Liraglutide with insulin improves poorly controlled Type 1 diabetes

Related Stories

Liraglutide with insulin improves poorly controlled Type 1 diabetes

June 25, 2012
Obese adults with poorly controlled Type 1 diabetes can better control their blood sugar by adding liraglutide, a Type 2 diabetes drug, to their insulin therapy, a new study finds. The results, which will be presented at ...

Combination therapy for type 1 diabetes improves blood glucose control

August 4, 2016
A combination of three medications—dapagliflozin, liraglutide and insulin—helped people with Type 1 diabetes improve blood sugar control and lose weight, according to a new study published in the Endocrine Society's Journal ...

Liraglutide augments weight loss in pre-type 2 diabetes

August 15, 2013
(HealthDay)—For patients at high risk of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), liraglutide in additional to calorie restriction is associated with more weight loss and improvements in insulin ...

Study suggests drug significantly improves glycemic control in type one diabetics on insulin

June 15, 2011
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control ...

Drug for type 2 diabetes provides significant benefits to type 1 diabetic patients

September 14, 2017
A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes ...

Drug helps patients with diabetes lose weight

August 18, 2015
Among overweight and obese patients with type 2 diabetes, daily injection of the diabetes drug liraglutide with a modified insulin pen device, in addition to diet and exercise, resulted in greater weight loss over 56 weeks ...

Recommended for you

Researchers cure type 2 diabetes and obesity in mice using gene therapy

July 10, 2018
A research team from the UAB led by Professor Fatima Bosch has managed to cure obesity and type 2 diabetes in mice using gene therapy.

Human clinical trial reveals verapamil as an effective type 1 diabetes therapy

July 9, 2018
Researchers at the University of Alabama at Birmingham Comprehensive Diabetes Center have discovered a safe and effective novel therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent ...

New targets found to reduce blood vessel damage in diabetes

July 9, 2018
In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells start to come apart as early steps in the destruction of our vasculature.

Insurance gaps linked to five-fold rise in hospital stays for adults with type 1 diabetes

July 9, 2018
For a million American adults, living with type 1 diabetes means a constant need for insulin medication, blood sugar testing supplies and specialized care, to keep them healthy and prevent a crisis that could end up in an ...

Abnormal branched-chain amino acid breakdown may raise diabetes risk

July 5, 2018
In the U.S., about five out of 100 expectant mothers develop gestational diabetes mellitus (GDM), a temporary form of diabetes in which hormonal changes disrupt insulin function. Although GDM is often symptomless and subsides ...

Air pollution contributes significantly to diabetes globally

June 30, 2018
New research links outdoor air pollution—even at levels deemed safe—to an increased risk of diabetes globally, according to a study from Washington University School of Medicine in St. Louis and the Veterans Affairs (VA) ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.